Showing posts with the label Protagonist Therapeutics

Protagonist's Hepcidin Mimetic Candidate PTG-300 Receives Fast Track Designation from the U.S. Food and Drug Administration for Development in the Treatment of Polycythemia Vera

IndustryPRwire -- Protagonist Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PTG-300 in the treatment of polycythemia vera, a rare disea…

Protagonist Therapeutics Announces Advancement of Oral IL-23 Receptor Antagonists Program in Collaboration with Janssen

Protagonist Therapeutics announced that two additional oral peptide IL-23 receptor antagonist candidates from its collaboration agreement with Janssen Biotec have been selected for advancement into c…
Subscribe Our Newsletter